In fact, patients with high ETV1 frequently had a metastatic disease, and are associated with a poor prognosis; furthermore, patients with high ETV1 expression and loss of PTEN displayed a much poorer disease-free survival [116]. This evidence concerns the gene ETV1 and metastatic neoplasm.